MA55748A - Procédés de détection d'aav - Google Patents

Procédés de détection d'aav

Info

Publication number
MA55748A
MA55748A MA055748A MA55748A MA55748A MA 55748 A MA55748 A MA 55748A MA 055748 A MA055748 A MA 055748A MA 55748 A MA55748 A MA 55748A MA 55748 A MA55748 A MA 55748A
Authority
MA
Morocco
Prior art keywords
aav
detection methods
detection
methods
aav detection
Prior art date
Application number
MA055748A
Other languages
English (en)
Inventor
Xiaoying Jin
Lin Liu
Catherine R O'riordan
Kate Zhang
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=59762045&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA55748(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of MA55748A publication Critical patent/MA55748A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/04—Preparation or injection of sample to be analysed
    • G01N30/06—Preparation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/72—Mass spectrometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/72—Mass spectrometers
    • G01N30/7233—Mass spectrometers interfaced to liquid or supercritical fluid chromatograph
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14123—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14151—Methods of production or purification of viral material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N2030/022—Column chromatography characterised by the kind of separation mechanism
    • G01N2030/027—Liquid chromatography
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G01N2333/075—Adenoviridae

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Photoreceptors In Electrophotography (AREA)
MA055748A 2016-08-15 2017-08-14 Procédés de détection d'aav MA55748A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662375314P 2016-08-15 2016-08-15

Publications (1)

Publication Number Publication Date
MA55748A true MA55748A (fr) 2022-03-02

Family

ID=59762045

Family Applications (1)

Application Number Title Priority Date Filing Date
MA055748A MA55748A (fr) 2016-08-15 2017-08-14 Procédés de détection d'aav

Country Status (23)

Country Link
US (5) US11698377B2 (fr)
EP (2) EP3851449A1 (fr)
JP (3) JP7021191B2 (fr)
KR (5) KR102538037B1 (fr)
CN (2) CN110168080B (fr)
AU (2) AU2017312951B2 (fr)
CA (1) CA3033856A1 (fr)
CL (2) CL2019000392A1 (fr)
CR (1) CR20190127A (fr)
CY (1) CY1124364T1 (fr)
DK (1) DK3497207T3 (fr)
ES (1) ES2863674T3 (fr)
HU (1) HUE053747T2 (fr)
IL (3) IL264819B2 (fr)
MA (1) MA55748A (fr)
MX (2) MX2019001938A (fr)
NZ (3) NZ791267A (fr)
PH (1) PH12019500316A1 (fr)
SG (2) SG10201913002QA (fr)
TN (1) TN2019000047A1 (fr)
TW (2) TW202309068A (fr)
WO (1) WO2018035059A1 (fr)
ZA (2) ZA201900945B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201508026D0 (en) 2015-05-11 2015-06-24 Ucl Business Plc Capsid
SG10201913002QA (en) 2016-08-15 2020-03-30 Genzyme Corp Methods for detecting aav
MX2019010275A (es) 2017-02-28 2019-10-15 Univ Pennsylvania Novedoso vector del subtipo f del virus adenoasociado (aav) y usos de este.
JOP20190200A1 (ar) 2017-02-28 2019-08-27 Univ Pennsylvania تركيبات نافعة في معالجة ضمور العضل النخاعي
IL276859B2 (en) * 2018-02-27 2025-12-01 Univ Pennsylvania Novel adeno-associated virus (aav) vectors, aav vectors having reduced capsid deamidation and uses therefor
AU2019228504B2 (en) 2018-02-27 2025-06-26 The Trustees Of The University Of Pennsylvania Novel adeno-associated virus (AAV) vectors, AAV vectors having reduced capsid deamidation and uses therefor
US20210010028A1 (en) * 2018-03-06 2021-01-14 Voyager Therapeutics, Inc. Insect cell manufactured partial self-complementary aav genomes
US11391707B2 (en) * 2018-07-27 2022-07-19 Waters Technologies Corporation Liquid chromatography/mass spectrometry methods for the analysis of polar molecules
WO2020041498A1 (fr) * 2018-08-21 2020-02-27 Massachusetts Eye And Ear Infirmary Compositions et procédés pour moduler l'efficacité de transduction de virus adéno-associés
CN113272649B (zh) * 2018-10-25 2024-03-12 瑞泽恩制药公司 用于分析病毒衣壳蛋白组成的方法
US12565645B2 (en) * 2019-04-11 2026-03-03 Regenxbio Inc. Methods of size exclusion chromatography for the characterization of recombinant adeno-associated virus compositions
US11841352B2 (en) * 2019-07-31 2023-12-12 Thermo Finnigan Llc Determination and correction of retention time and mass/charge shifts in LC-MS experiments
KR20220121823A (ko) * 2020-01-03 2022-09-01 사렙타 쎄러퓨틱스 인코퍼레이티드 Aav 캡시드 단백질을 분석하기 위한 방법
JP2023513004A (ja) 2020-01-29 2023-03-30 ジェンザイム・コーポレーション 眼科遺伝子療法のための改変されたアデノ随伴ウイルスカプシドタンパク質およびその使用方法
CN111517359B (zh) * 2020-04-23 2021-08-20 江南大学 一种手性硫化铜超粒子的合成方法
RU2748540C1 (ru) * 2021-02-08 2021-05-26 Автономная некоммерческая образовательная организация высшего образования "Сколковский институт науки и технологий" Способ детектирования вируса SARS-CoV-2 методом масс-спектрометрии
WO2022175728A1 (fr) * 2021-02-19 2022-08-25 Waters Technologies Corporation Procédés de cartographie peptidique de protéines du virus adéno-as associé (vaa)
EP4328292A1 (fr) * 2021-04-20 2024-02-28 Universal Bio-Sampling Inc. Carte de rétention d'échantillon et procédé d'inspection d'échantillon l'utilisant
IL309735A (en) * 2021-07-12 2024-02-01 Regeneron Pharma Natural continuous mass spectrometry methods for viral particle screening
IL309733A (en) * 2021-07-12 2024-02-01 Regeneron Pharma Methods for Viral Particle Characterization Using Liquid Chromatography-2D Mass Spectrometry
CN113552349B (zh) * 2021-07-30 2022-07-19 上海勉亦生物科技有限公司 Aav蛋白外壳的检测方法
EP4462114A4 (fr) * 2022-01-06 2025-04-16 FUJIFILM Corporation Procédé et kit pour identifier un site d'acides aminés liés à un sucre dans une protéine
CN120712363A (zh) * 2023-03-03 2025-09-26 赛多利斯生物分析仪器公司 用于定量病毒衣壳的方法
US20240418730A1 (en) * 2023-06-19 2024-12-19 Regeneron Pharmaceuticals, Inc. Host cell protein analysis for adeno-associated virus (aav)-based gene therapy
WO2025101795A1 (fr) * 2023-11-08 2025-05-15 Oxford Biomedica (Us) Llc Produit du virus adéno-associé appauvri par désamidation

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5540931A (en) 1989-03-03 1996-07-30 Charles W. Hewitt Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
US6204059B1 (en) * 1994-06-30 2001-03-20 University Of Pittsburgh AAV capsid vehicles for molecular transfer
JP2001500015A (ja) 1996-09-06 2001-01-09 トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア Ｔ７ポリメラーゼを利用する組換えアデノ随伴ウイルスの誘導可能な製造方法
US6989264B2 (en) 1997-09-05 2006-01-24 Targeted Genetics Corporation Methods for generating high titer helper-free preparations of released recombinant AAV vectors
US6566118B1 (en) 1997-09-05 2003-05-20 Targeted Genetics Corporation Methods for generating high titer helper-free preparations of released recombinant AAV vectors
EP2369002A1 (fr) 1999-08-09 2011-09-28 Targeted Genetics Corporation Améliorations de l'expression d'une séquence de nucléotides hétérologues à brin unique à partir de vecteurs viraux recombinants par la désignation de la séquence de manière à ce qu'elle forme des paires de bases intrabrins
ATE318923T1 (de) 2000-06-01 2006-03-15 Univ North Carolina Doppelsträngige parvovirus-vektoren
US6723551B2 (en) 2001-11-09 2004-04-20 The United States Of America As Represented By The Department Of Health And Human Services Production of adeno-associated virus in insect cells
SG10202108118RA (en) 2001-11-13 2021-08-30 Univ Pennsylvania A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
US8802080B2 (en) 2002-05-01 2014-08-12 University Of Florida Research Foundation, Inc. Raav expression systems for genetic modification of specific capsid proteins
WO2004049385A2 (fr) 2002-11-22 2004-06-10 Caprion Pharmaceuticals, Inc. Mise en correspondance de constellation et utilisations
WO2004075861A2 (fr) 2003-02-26 2004-09-10 Children's Hospital, Inc. Production de virus recombines adeno associes
US7261544B2 (en) 2003-05-21 2007-08-28 Genzyme Corporation Methods for producing preparations of recombinant AAV virions substantially free of empty capsids
EP1486567A1 (fr) 2003-06-11 2004-12-15 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Vecteur derivé d'un virus associé aux adenovirus pour la thérapie génique
US9441244B2 (en) 2003-06-30 2016-09-13 The Regents Of The University Of California Mutant adeno-associated virus virions and methods of use thereof
US8283151B2 (en) 2005-04-29 2012-10-09 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Isolation, cloning and characterization of new adeno-associated virus (AAV) serotypes
AU2006304997B2 (en) 2005-10-20 2012-03-01 Uniqure Ip B.V. Improved AAV vectors produced in insect cells
WO2007120542A2 (fr) 2006-03-30 2007-10-25 The Board Of Trustees Of The Leland Stanford Junior University Bibliothèque de capsides aav et protéines de capsides aav
WO2010031865A1 (fr) 2008-09-19 2010-03-25 Charitē Universitätsmedizin Berlin Identification et caractérisation de vecteurs de thérapie génique viraux recombinants
US8889641B2 (en) 2009-02-11 2014-11-18 The University Of North Carolina At Chapel Hill Modified virus vectors and methods of making and using the same
KR101812813B1 (ko) 2009-06-16 2017-12-27 젠자임 코포레이션 재조합 ａａｖ 벡터에 대한 개선된 정제 방법
EP3567106A1 (fr) 2010-04-23 2019-11-13 University of Massachusetts Vecteurs aav de ciblage du système nerveux central et leurs procédés d'utilisation
US20130217789A1 (en) * 2010-09-03 2013-08-22 North Carolina Central University Biodegradable liquogel and ph sensitive nanocarriers
US8663624B2 (en) 2010-10-06 2014-03-04 The Regents Of The University Of California Adeno-associated virus virions with variant capsid and methods of use thereof
SG10202007803QA (en) 2011-02-17 2020-09-29 Univ Pennsylvania Compositions and methods for altering tissue specificity and improving aav9-mediated gene transfer
EP3147295B2 (fr) 2011-08-24 2023-11-22 The Board of Trustees of the Leland Stanford Junior University Nouvelles protéines de capside avv pour le transfert d'acides nucléiques
JP6342886B2 (ja) * 2012-04-18 2018-06-13 ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィアＴｈｅ Ｃｈｉｌｄｒｅｎ’Ｓ Ｈｏｓｐｉｔａｌ Ｏｆ Ｐｈｉｌａｄｅｌｐｈｉａ Ａａｖカプシドバリアントを使用した高効率な遺伝子導入のための組成物及び方法
US20140017716A1 (en) * 2012-07-11 2014-01-16 Siscapa Assay Technologies, Inc. Proteolytic digestion kit with dried reagents
GB201401707D0 (en) 2014-01-31 2014-03-19 Sec Dep For Health The Adeno-associated viral vectors
EP4450630A3 (fr) 2014-03-10 2025-01-29 uniQure IP B.V. Vecteurs aav encore améliorés produits dans des cellules d'insectes
SG10201913002QA (en) 2016-08-15 2020-03-30 Genzyme Corp Methods for detecting aav

Also Published As

Publication number Publication date
CA3033856A1 (fr) 2018-02-22
US12123880B2 (en) 2024-10-22
US20210041451A1 (en) 2021-02-11
TW202309068A (zh) 2023-03-01
KR20260036296A (ko) 2026-03-16
NZ791263A (en) 2025-11-28
CL2019002912A1 (es) 2020-03-06
HUE053747T2 (hu) 2021-07-28
KR102738219B1 (ko) 2024-12-05
KR20190039253A (ko) 2019-04-10
US20240044910A1 (en) 2024-02-08
KR102922101B1 (ko) 2026-02-03
US12298313B1 (en) 2025-05-13
IL264819B1 (en) 2024-06-01
IL323969A (en) 2025-12-01
KR20230078834A (ko) 2023-06-02
EP3497207B1 (fr) 2021-01-06
CN118688363A (zh) 2024-09-24
JP2022064980A (ja) 2022-04-26
WO2018035059A1 (fr) 2018-02-22
CY1124364T1 (el) 2022-07-22
RU2019107207A3 (fr) 2021-04-29
MX2019001938A (es) 2019-07-04
IL312792B1 (en) 2025-11-01
KR20240172773A (ko) 2024-12-10
MX2023009081A (es) 2023-08-08
BR112019002934A2 (pt) 2019-05-14
RU2019107207A (ru) 2020-09-15
TN2019000047A1 (en) 2020-07-15
PH12019500316A1 (en) 2019-08-05
ZA202101002B (en) 2024-07-31
KR102538037B1 (ko) 2023-05-30
KR102425289B1 (ko) 2022-07-27
AU2024200349A1 (en) 2024-02-08
CR20190127A (es) 2019-06-25
AU2024200349B2 (en) 2026-05-14
TWI781953B (zh) 2022-11-01
IL312792B2 (en) 2026-03-01
CN110168080A (zh) 2019-08-23
AU2017312951B2 (en) 2024-02-08
DK3497207T3 (da) 2021-03-22
CL2019000392A1 (es) 2019-05-10
CN110168080B (zh) 2024-05-31
WO2018035059A9 (fr) 2019-03-14
EP3851449A1 (fr) 2021-07-21
NZ791267A (en) 2025-11-28
US20250147042A1 (en) 2025-05-08
JP7021191B2 (ja) 2022-02-16
JP2019533803A (ja) 2019-11-21
KR20220107327A (ko) 2022-08-02
SG11201901221YA (en) 2019-03-28
AU2017312951A1 (en) 2019-04-04
US11698377B2 (en) 2023-07-11
IL264819A (fr) 2019-04-30
US20250027951A1 (en) 2025-01-23
ZA201900945B (en) 2021-06-30
IL264819B2 (en) 2024-10-01
TW201825898A (zh) 2018-07-16
NZ751711A (en) 2025-11-28
US20250138024A1 (en) 2025-05-01
SG10201913002QA (en) 2020-03-30
ES2863674T3 (es) 2021-10-11
IL312792A (en) 2024-07-01
EP3497207A1 (fr) 2019-06-19
JP2024023460A (ja) 2024-02-21

Similar Documents

Publication Publication Date Title
HUE053747T2 (hu) Eljárások AAV kimutatására
EP3430731A4 (fr) Architecture d'iugw
EP3464313A4 (fr) Nucléotides modifiés 5 '-cyclo-phosphonate
EP3519441A4 (fr) Molécules de récepteurs d'engloutissement chimériques
EP3387023A4 (fr) Procédés de récupération d'hydrocarbure
EP3408402A4 (fr) Détection magnéto-électrochimique
EP3372456A4 (fr) Dispositif de détection d'obstacle
EP3488069A4 (fr) Système d'écran
EP3513579A4 (fr) Détection de lieu
EP3415071A4 (fr) Système d'endoscope
EP3371024A4 (fr) Système d'alarme perfectionné
EP3319037A4 (fr) Dispositif de détection d'objet
EP3622431A4 (fr) Détection de compromission cryptographique-rançonneuse
EP3443293A4 (fr) Capteurs d'effort
EP3515503A4 (fr) Lymphocytes modifiés
MA41296A (fr) Procédés de transdifférenciation et procédés d'utilisation de ceux-ci
EP3248528C0 (fr) Système d'endoscope
MA46927A (fr) Procédés de détection du cancer
EP3433383A4 (fr) Procédés d'amplification quantitative
EP3350072A4 (fr) Système d'aileron réglable
EP3529947A4 (fr) Système d'interface
EP3359994A4 (fr) Système d'autopropulsion
MA41842A (fr) Nouveaux procédés de sélection d'épitope
EP3512403A4 (fr) Système d'inspection d'orifice
KR102213006B9 (ko) 멀티 광 섬유 감지 시스템